G

GlobeImmune, Inc.

14 employees

GlobeImmune focused on developing products for the treatment of cancer and infectious diseases based on our proprietary Tarmogen® platform.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics
Medical

Date founded

1995

Funding rounds raised

Total raised

$41M

from 13 investors over 13 rounds

G

GlobeImmune, Inc. raised $7.5M on January 1, 2013

Investors: SternAegis Ventures

G

GlobeImmune, Inc. raised $41M on September 26, 2007

Investors: Handshake Ventures, BNY Mellon, Washington Research Foundation, Richard King Mellon Foundation and Wexford Capital LP

G

GlobeImmune, Inc. raised $34M on December 16, 2005

Investors: Lilly Ventures, Morgenthaler, HealthCare Ventures LLC, Adams Street Partners, Mass General Brigham and Biogen Idec

G

GlobeImmune, Inc. raised $8M on June 18, 2003

Investors: HealthCare Ventures LLC

FAQ